Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 2182

2.

Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells.

Janowska-Wieczorek A, Marquez LA, Matsuzaki A, Hashmi HR, Larratt LM, Boshkov LM, Turner AR, Zhang MC, Edwards DR, Kossakowska AE.

Br J Haematol. 1999 May;105(2):402-11.

PMID:
10233411
3.
4.

Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat.

Knittel T, Mehde M, Grundmann A, Saile B, Scharf JG, Ramadori G.

Histochem Cell Biol. 2000 Jun;113(6):443-53.

PMID:
10933221
5.

Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis.

Tanney DC, Feng L, Pollock AS, Lovett DH.

Dev Dyn. 1998 Sep;213(1):121-9.

6.
7.
8.

[Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].

Hu XX, Li L, Li DR, Zhang W, Cheng XQ, Zhang JQ, Tang BJ.

Ai Zheng. 2004 Oct;23(10):1194-8. Chinese.

PMID:
15473934
10.

MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues.

Birkedal-Hansen B, Pavelic ZP, Gluckman JL, Stambrook P, Li YQ, Stetler-Stevenson WG.

Oral Dis. 2000 Nov;6(6):376-82.

PMID:
11355270
11.

Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.

Pesta M, Holubec L Jr, Topolcan O, Cerna M, Rupert K, Holubec LS, Treska V, Kormunda S, Elgrova L, Finek J, Cerny R.

Anticancer Res. 2005 Sep-Oct;25(5):3387-91.

12.

Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukaemias and myelodysplastic syndromes.

Travaglino E, Benatti C, Malcovati L, Della Porta MG, Gallì A, Bonetti E, Rosti V, Cazzola M, Invernizzi R.

Eur J Haematol. 2008 Mar;80(3):216-26. Epub 2007 Dec 10.

PMID:
18081721
13.

Matrix metalloproteinase and tissue inhibitors of metalloproteinase secretion by haematopoietic and stromal precursors and their production in normal and leukaemic long-term marrow cultures.

Marquez-Curtis LA, Dobrowsky A, Montaño J, Turner AR, Ratajczak J, Ratajczak MZ, Janowska-Wieczorek A.

Br J Haematol. 2001 Dec;115(3):595-604.

PMID:
11736941
14.

Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.

Sutinen M, Kainulainen T, Hurskainen T, Vesterlund E, Alexander JP, Overall CM, Sorsa T, Salo T.

Br J Cancer. 1998 Jun;77(12):2239-45.

16.

Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis.

Lichtinghagen R, Seifert T, Kracke A, Marckmann S, Wurster U, Heidenreich F.

J Neuroimmunol. 1999 Sep 1;99(1):19-26.

PMID:
10496173
17.

Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes--first experience with their reversal.

Nüssler V, Pelka-Fleischer R, Zwierzina H, Nerl C, Beckert B, Gullis E, Gieseler F, Bock S, Bartl R, Petrides PE, et al.

Ann Hematol. 1994;69 Suppl 1:S25-9.

PMID:
7914749
19.
Items per page

Supplemental Content

Write to the Help Desk